NCT00114946View on ClinicalTrials.gov

A Study to Compare Two Avastin-Based Treatment Regimens for the Treatment of Metastatic Colorectal Cancer

PHASE4TerminatedINTERVENTIONAL
Enrollment

800

Participants

Timeline

Start Date

May 31, 2005

Study Completion Date

December 31, 2007

Conditions
Colorectal Cancer
Interventions
DRUG

Avastin

Sponsors

Lead Sponsor

Genentech, Inc.
All Listed Sponsors
lead

Genentech, Inc.

INDUSTRY

NCT00114946 - A Study to Compare Two Avastin-Based Treatment Regimens for the Treatment of Metastatic Colorectal Cancer | Biotech Hunter | Biotech Hunter